TANTA UNIVERSITY
🇪🇬Egypt
- Country
- 🇪🇬Egypt
- Ownership
- Private
- Established
- 1972-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.tanta.edu.eg
Effect of Hebal and Synthetic Medicamentss on Enterococcus Feacalis
Phase 2
Not yet recruiting
- Conditions
- Effective Intracanal Medicaments Against Enterococcus Faecalis
- Interventions
- Dietary Supplement: curcuminDietary Supplement: olive leaves extract
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2023-08-23
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 32
- Registration Number
- NCT06006663
Mid-transverse Process to Pleura Block in Pediatric Thoracotomy
Not Applicable
Not yet recruiting
- Conditions
- Pediatric SurgeryUltrasound Guided BlockAnalgesia
- Interventions
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 50
- Registration Number
- NCT05999734
Lung Recruitment Manoeuvre in Morbidly Obese Patients Underdoing Laparoscopic Bariatric Surgery
Not Applicable
Completed
- Conditions
- Bariatric SurgeryObesity, Morbid
- Interventions
- Device: Lung Recruitment ConventionalDevice: Lung Recruitment Ultrasound
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 78
- Registration Number
- NCT06000969
- Locations
- 🇪🇬
Tanta University, Tanta, Algharbia, Egypt
🇪🇬Tanta University hospitals, Tanta, Egypt
Three Regimens of Ketamine Infusion in Complex Regional Pain Syndrome
Phase 4
Recruiting
- Conditions
- Ketamine InfusionComplex Regional Pain Syndromes
- Interventions
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 75
- Registration Number
- NCT05997134
- Locations
- 🇪🇬
Tanta University, Tanta, El-garbia, Egypt
Diabetic Small Fiber Neuropathy: Clinical, Electrophysiological and Neurosonographic Study
Completed
- Conditions
- Small Fiber NeuropathyDiabetic NeuropathiesDiabetic Peripheral NeuropathyPainful Diabetic NeuropathyDiabetic PolyneuropathyAutonomic Neuropathy
- Interventions
- Diagnostic Test: Clinical Evaluation/QuestionnairesDiagnostic Test: Nerve Conduction StudyDiagnostic Test: Small fiber electrodiagnostic testsDiagnostic Test: Nerve UltrasoundDiagnostic Test: Skin Biopsy
- First Posted Date
- 2023-08-15
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 45
- Registration Number
- NCT05993871
- Locations
- 🇪🇬
Ahmed Sami Mahmoud Alkotami, Kafr Ash Shaykh, Egypt
The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children
Completed
- Conditions
- Pediatric ALLFluid Overload
- First Posted Date
- 2023-08-15
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 85
- Registration Number
- NCT05992246
- Locations
- 🇪🇬
Faculty of medicine, Tanta university, Tanta, El Gharbyia, Egypt
Double Closure of Nasal Layer in Alveolar Cleft Grafting
Not Applicable
Completed
- Conditions
- Alveolar Cleft
- Interventions
- Procedure: platelet rich fibrinProcedure: collagen membrane
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 24
- Registration Number
- NCT05988086
- Locations
- 🇪🇬
Egypt, Tanta, Egypt
Bone Lid Technique Versus Standard Technique for Treatment of Mandibular Lesions
Not Applicable
Completed
- Conditions
- Mandible TumorMandible CystMandibular Diseases
- Interventions
- Device: standard techniqueDevice: bone lid technique
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 24
- Registration Number
- NCT05987930
- Locations
- 🇪🇬
Faculty of Dentistry, Tanta University, Tanta, Egypt
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2023-11-24
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 50
- Registration Number
- NCT05977465
- Locations
- 🇪🇬
Faculty of pharmacy, Tanta, Egypt
Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis
Phase 2
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: Ursodeoxycholic acid (UDCA) 500 mgDrug: Placebo
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Tanta University
- Target Recruit Count
- 60
- Registration Number
- NCT05973370
- Locations
- 🇪🇬
Menoufia University Hospital, Shibīn Al Kawm, Egypt
© Copyright 2025. All Rights Reserved by MedPath